The hallmark of ITP is the presence of autoantibodies against platelet surface glycoproteins such as GPIIb/IIIa and GPIb/IX.[17] Complement activation via the classical pathway may contribute to platelet destruction in some patients. The gene discussed is ART4; the disease is autoimmune thrombocytopenic purpura.